Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
European Journal of Medicinal Chemistry|March 9, 2023
N-sulfonyl peptide-hybrids as a new class of dengue virus protease inhibitorsSomayeh Behrouz, Nikos Kühl, Christian D KleinEuropean Journal of Medicinal Chemistry|July 21, 2022
Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteasesNikos Kühl, Johannes Lang, Mila M Leuthold, et al.Drug Discovery Today|July 5, 2022
Antibody-drug conjugates: What drives their progress?Giulia Pander, Philipp Uhl, Nikos Kühl, et al.Bioorganic & Medicinal Chemistry|September 30, 2021
The spectrum between substrates and inhibitors: Pinpointing the binding mode of dengue protease ligands with modulated basicity and hydrophobicityTonko Dražić, Nikos Kühl, Nicole Gottscheber, et al.Journal of Medicinal Chemistry|April 14, 2021
Beyond Basicity: Discovery of Nonbasic DENV-2 Protease Inhibitors with Potent Activity in Cell CultureNikos Kühl, Mila M Leuthold, Mira A M Behnam, et al.SLAS Discovery : Advancing Life Sciences R & D|June 21, 2021
Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET AssayTonko Dražić, Nikos Kühl, Mila M Leuthold, et al.Journal of Medicinal Chemistry|July 2, 2020
A New Class of Dengue and West Nile Virus Protease Inhibitors with Submicromolar Activity in Reporter Gene DENV-2 Protease and Viral Replication AssaysNikos Kühl, Dominik Graf, Josephine Bock, et al.Antiviral Research|December 7, 2024
Antiviral drug discovery with an optimized biochemical dengue protease assay: Improved predictive power for antiviral efficacyJohannes Lang, Sudip Kumar Dutta, Mila M Leuthold, et al.Pageof 1